PS02.083: CIRCULATING CELL FREE TUMOR DNA FOR DISEASE MONITORING AFTER NEOADJUVANT CHEMORADIOTHERAPY FOR ESOPHAGEAL CANCER: PROOF-OF-PRINCIPLE
Ben M. Eyck(Erasmus MC Cancer Institute), W. N. M. Dinjens(Erasmus MC), John W.M. Martens(Erasmus MC), Maurice P.H.M. Jansen(Erasmus MC Cancer Institute), J. Jan B. van Lanschot, Bas P. L. Wijnhoven(Inserm), Berend Van Der Wilk(Erasmus MC), Bo Jan Noordman(Erasmus MC Cancer Institute), Peggy N. Atmodimedjo(Erasmus MC Cancer Institute), Sjoerd M. Lagarde(University of Amsterdam)
Cited by 0
Related Papers
Extended Transthoracic Resection Compared with Limited Transhiatal Resection for Adenocarcinoma of the Esophagus
|New England Journal of Medicine|2002|1.6k
Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial
|Journal of Clinical Oncology|2021|788